Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
332,525,463
-
Total 13F shares
-
80,141,199
-
Share change
-
+4,853,412
-
Total reported value
-
$119,307,433
-
Put/Call ratio
-
3.4%
-
Price per share
-
$1.49
-
Number of holders
-
136
-
Value change
-
+$7,804,791
-
Number of buys
-
55
-
Number of sells
-
57
Institutional Holders of PRECIGEN, INC. - Common Stock (PGEN) as of Q1 2025
As of 31 Mar 2025 PRECIGEN, INC. - Common Stock (PGEN) had 136 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 80,141,199 shares of stock of the company.
Largest 10 holders included Patient Capital Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock, Inc., VANGUARD GROUP INC, IRIDIAN ASSET MANAGEMENT LLC/CT, GEODE CAPITAL MANAGEMENT, LLC, Parkman Healthcare Partners LLC, STATE STREET CORP, Schonfeld Strategic Advisors LLC, and CHARLES SCHWAB INVESTMENT MANAGEMENT INC.
This table shows 137 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.